Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and their handbags – the one item they do not leave home without – and urges women to take the Handbags & Hearts pledge to carry aspirin at all times to be prepared for a sudden heart attack. Being prepared by carrying aspirin, knowing the symptoms of heart attack and not putting off calling 911 if a heart attack is suspected, can be the difference between life and death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61582-bayer-healthcare-vanessa-williams-handbags-and-hearts-pledge-carry-aspirin
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
The American Pain Foundation (APF) announced today the launch of new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) as a part of its PainSAFE™ educational initiative. The new information will be launched with a national public service announcement (PSA) emphasizing the safe use of pain treatment options, particularly medications containing NSAIDs (aspirin, ibuprofen, naproxen) and acetaminophen (Tylenol, APAP). APF is the nation’s largest consumer advocacy organization dedicated to people with pain.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/painfoundation/49865/
